Impact of achondroplasia on Latin American patients: a systematic review and meta-analysis of observational studies

Registro completo de metadados
MetadadosDescriçãoIdioma
Autor(es): dc.contributorHospital de Pediatría “Prof. Dr. Juan P. Garrahan”-
Autor(es): dc.contributorUniversidade de São Paulo (USP)-
Autor(es): dc.contributorFundacion Cardioinfantil-Instituto de Cardiologia-
Autor(es): dc.contributorUniversidade Estadual Paulista (UNESP)-
Autor(es): dc.contributorBioMarin Pharmaceutical Inc-
Autor(es): dc.contributorBioMarin Farmaceutica LTDA-
Autor(es): dc.contributorInstituto Nacional Fernandes Figueira (IFF)-
Autor(es): dc.creatorFano, Virginia-
Autor(es): dc.creatorKim, Chong A.-
Autor(es): dc.creatorRosselli, Pablo-
Autor(es): dc.creatorDib, Regina El-
Autor(es): dc.creatorShediac, Renée-
Autor(es): dc.creatorMagalhães, Tatiana-
Autor(es): dc.creatorMesojedovas, Debora-
Autor(es): dc.creatorLlerena, Juan-
Data de aceite: dc.date.accessioned2025-08-21T22:47:12Z-
Data de disponibilização: dc.date.available2025-08-21T22:47:12Z-
Data de envio: dc.date.issued2022-04-28-
Data de envio: dc.date.issued2022-04-28-
Data de envio: dc.date.issued2022-11-30-
Fonte completa do material: dc.identifierhttp://dx.doi.org/10.1186/s13023-021-02142-3-
Fonte completa do material: dc.identifierhttp://hdl.handle.net/11449/223175-
Fonte: dc.identifier.urihttp://educapes.capes.gov.br/handle/11449/223175-
Descrição: dc.descriptionBackground: Achondroplasia (ACH), the most common form of disproportionate short stature, is caused by a pathogenic variant in the fibroblast growth factor receptor 3 gene. Recent advances in drug therapy for ACH have highlighted the importance of elucidating the natural history and socioeconomic burden of this condition. Recognition that there are many potential issues for the patient with ACH is the first step in planning cost-effective interventions in Latin America (LATAM), a vast geographic territory comprising countries with multicultural characteristics and wide socioeconomic differences. We conducted a systematic literature review to characterize the impact of ACH on affected individuals and on healthcare resources in LATAM countries. Methods: Searches of the global medical literature as well as regional and local medical literature up to August 2020. Observational studies on patients with ACH from any LATAM country. Pairs of reviewers independently screened eligible articles, extracted data from included studies, and assessed their risk of bias. Results: Fifty-three unique studies (28 case series and cross-sectional studies and 25 case reports) including data on 1604 patients were eligible. Of these studies, 11 had data available for meta-analysis. Both premature mortality and all-cause mortality in the pooled studies was 15% [95% Confidence Interval (CI) 1.0E−3 to 0.47; I2 = 82.9%, p = 0.0029; three studies, n = 99 patients]. Frequency of cardio-respiratory-metabolic disorders was 17% [95% CI 0.04–0.37; I2 = 90.3%, p < 0.0001; four studies, n = 230 patients]; nervous system disorders was 18% [95% CI 0.07–0.33; I2 = 84.6%, p < 0.0001; six studies, n = 262 patients]; ear, nose, throat and speech disorders was 32% [95% CI 0.18–0.48; I2 = 73.4%, p = 0.0046; five studies, n = 183 patients]; and spinal issues including stenosis, compression and associated pain was 24% [95% CI 0.07–0.47; I2 = 91.3%, p < 0.0001; five studies, n = 235 patients]. Conclusions: There is currently evidence of high clinical burden in ACH patients in LATAM countries. Establishing the impact of ACH provides the necessary foundation for planning tailored and effective public health interventions.-
Descrição: dc.descriptionBioMarin Pharmaceutical-
Descrição: dc.descriptionHospital de Pediatría “Prof. Dr. Juan P. Garrahan”-
Descrição: dc.descriptionInstituto da Criança HC – FMUSP, SP-
Descrição: dc.descriptionFundacion Cardioinfantil-Instituto de Cardiologia-
Descrição: dc.descriptionUNESP ‐ Univ Estadual Paulista Department of Biosciences and Oral Diagnosis Institute of Science and Technology, SP-
Descrição: dc.descriptionBioMarin Pharmaceutical Inc-
Descrição: dc.descriptionMedical Affairs Latin America BioMarin Farmaceutica LTDA, SP-
Descrição: dc.descriptionInstituto Nacional Fernandes Figueira (IFF), Fundação Osvaldo Cruz, Av. Rui Barbosa 716, RJ-
Descrição: dc.descriptionUNESP ‐ Univ Estadual Paulista Department of Biosciences and Oral Diagnosis Institute of Science and Technology, SP-
Idioma: dc.languageen-
Relação: dc.relationOrphanet Journal of Rare Diseases-
???dc.source???: dc.sourceScopus-
Palavras-chave: dc.subjectAchondroplasia-
Palavras-chave: dc.subjectLatin America-
Palavras-chave: dc.subjectSkeletal dysplasia-
Título: dc.titleImpact of achondroplasia on Latin American patients: a systematic review and meta-analysis of observational studies-
Tipo de arquivo: dc.typevídeo-
Aparece nas coleções:Repositório Institucional - Unesp

Não existem arquivos associados a este item.